Cantitate/Preț
Produs
Total produse
Vezi coșul
Biologics for the Treatment of Rheumatoid Arthritis de Ronald van Vollenhoven

Biologics for the Treatment of Rheumatoid Arthritis

Autor Ronald van Vollenhoven
en Limba Engleză Paperback – 5 ian 2016
This book provides a comprehensive overview of the available biologic therapies whilst comparing them to standard disease modifying anti-rheumatic drugs, and discusses how best to determine which therapy is most appropriate for an individual patient in the framework of current guidelines. Biologics for the Treatment of Rheumatoid Arthritis is an up-to-date and concise practical guide to the latest therapeutic developments in this field. This book is an invaluable source of topical information for all rheumatologists and health care professionals treating patients with rheumatoid arthritis.
Citește tot Restrânge

Preț: 12184 lei

Preț vechi: 12826 lei
-5% Nou

Puncte Express: 183
Preț estimativ în valută:
2332€ • 2541$ • 1957£

Carte disponibilă

Livrare economică 27 noiembrie-11 decembrie
Livrare express 13-19 noiembrie pentru 2163 lei

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319131078
ISBN-10: 3319131079
Pagini: 100
Ilustrații: XIII, 132 p. 40 illus., 3 illus. in color.
Dimensiuni: 127 x 201 x 13 mm
Greutate: 0.16 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Adis
Locul publicării:Cham, Switzerland

Public țintă

Professional/practitioner

Cuprins

Disease overview.- General treatment aspects.- Overview of biologic therapies.- Cytokine inhibitors.- B-cell directed therapy.- T-cell directed therapy.- Novel biologics and small molecules with biologic-like effects.- Strategies for the optimal use of biologic agents in rheumatoid arthritis.- Considerations for special patient populations.- Conclusions and future outlook

Notă biografică

Professor Ronald F van Vollenhoven is Chief of the Unit for Clinical Therapy Research,Inflammatory Diseases (ClinTRID) at the Karolinska Institute, and of theClinical Trials Unit Rheumatology at the Karolinska University Hospital. Hereceived his MD and PhD degrees from the University of Leiden in TheNetherlands. After graduating in 1984 he pursuedimmunology research at Cornell Medical College in New York, followed by aresidency (specialty training) in internal medicine at the State University ofNew York at Stony Brook, and a fellowship in rheumatology at StanfordUniversity in Palo Alto following which he received American Board of InternalMedicine certification in both internal medicine and rheumatology. From 1993 to1998 Professor van Vollenhoven held a faculty appointment as AssistantProfessor of Medicine in the Division of Immunology and Rheumatology atStanford University, and from 1995 he was the Medical Services Chief andFellowship Director in that division. In 1998 Professor van Vollenhoven movedto Stockholm, Sweden, where he worked as a Senior Physician and Chief of theClinical Trials Unit in the Department of Rheumatology at the KarolinskaUniversity Hospital and Associate Professor of Rheumatology; and in 2010, hewas appointed in his current position as Professor and Unit Chief at theKarolinska Institute.

Professorvan Vollenhoven’s research interests focus around the development andsystematic evaluation of biologic and immunomodulatory treatments for therheumatic diseases. With his co-workers, he has established the Stockholmregistry for biological therapies (the STURE database) for this purpose, whichhas supported research projects relating to clinical efficacy, pharmacology,outcomes, and pharmacoeconomics. He has been principal investigator in manyclinical trials of novel therapies in rheumatic diseases and has contributed toa number of important investigator-initiated trials including the SWEFOT trial.He has published over 240 original papers, book chapters and reviews, and isEditor of the textbook Targeted Treatment of the RheumaticDiseases and associate-editor of Dubois’ Lupus Erythematosus.In 2004, Professor van Vollenhoven was awarded the Scandinavian Research FoundationPrize for excellence in clinical research in rheumatology, and he is anhonorary member of several rheumatology societies. He is the Editor-in-Chief ofLupus Science & Medicine, Chair of the EULAR Standing Committee on ClinicalAffairs, member of many editorial boards, past-chair of the SwedishRheumatology Society Professors’ Council, co-founder of the IRBIS registry forbiologics in systemic lupus erythematosus (SLE), the CERERRA registries collaboration,and the NORD-STAR collaboration for Nordic trials in the rheumatic diseases,and the initiator of the Treat-to-Target-in-SLE initiative. Professor vanVollenhoven lives just north of Stockholm with his wife and children aged 20and 16. Outside his professional life he is an avid classical pianist.

Caracteristici

A practical evidence-based overview of the available and emerging biologic treatments for rheumatoid arthritis.
This book also features a concise summary of the latest updates regarding biosimilars for this conditions.
Concise pocket-sized format makes it an ideal go-to resource for all rheumatologists treating patients with rheumatoid arthritis.
Written by an internationally renowned expert in the field.
Engaging images, illustrations, and figures highlight the up-to-date recommendations presented in the book.
Includes supplementary material: sn.pub/extras